External Directorships held by Company Directors

Summary by AI BETAClose X

Spirax Group plc announced that its Chair, Tim Cobbold, will join the board of Coats Group plc as a non-executive director and chair designate on July 1, 2026, becoming chair on August 1, 2026, in addition to his current role. This appointment is being disclosed in accordance with Listing Rule 6.4.9R, requiring notification of changes in directorships held by directors in other publicly quoted companies.

Disclaimer*

Spirax Group PLC
14 May 2026
 

 

14 May 2026

 

Spirax Group plc (the "Company")

Update on External Directorships held by Company Directors

 

Pursuant to Listing Rule 6.4.9R, requirement to give notice of a change in directorships held by directors in another publicly quoted company, the Company announces that Tim Cobbold, Chair of the Company, will join the board of Coats Group plc ('Coats'), a world-leading Tier 2 supplier of critical components to the apparel and footwear industries on 1 July 2026, as non-executive director and chair designate.

 

Tim will become chair of the board of Coats Group plc on 1 August 2026. This appointment is in addition to his existing role as chair of the Board of Spirax Group plc.

 

 

Enquiries:      

Spirax Group:                                                            +44 (0) 1242 535 000 

Mal Patel, Head of Investor Relations                          investors@spiraxgroup.com 

Hazel Meldrum, Group Head of Communications       communications@spiraxgroup.com 

Celine Barroche, Company Secretary                           +44 (0) 1242 535 276

 

About Spirax Group plc 

Spirax Group is positioned to play a critical role in enabling the industrial transition to net zero, aligned to our Purpose to create sustainable value for all our stakeholders as we engineer a more efficient, safer and sustainable world.  We put solving customers' problems at the heart of our total solutions approach.  Our global thermal energy and fluid technology solutions improve operating efficiency and safety in our customers' critical industrial processes.  Our new-to-world decarbonisation* solutions will use our proprietary technologies to electrify boilers, for the raising of steam, as well as the electrification of other critical industrial process heating applications.  

Spirax Group comprises three strong and aligned Businesses: Steam Thermal Solutions helps customers control and manage steam within their mission critical industrial applications, such as cleaning, sterilising, cooking and heating.  We are helping to put food safely on the world's tables and keeping our hospitals running. Electric Thermal Solutions has proprietary technologies that deliver electrification solutions at scale in industrial settings, including for the raising of steam, supporting our customers to achieve their net zero goals. We also deliver freeze protection and defrost solutions critical to aviation and space industries and ensure thermal uniformity in Semiconductor chip manufacturing to power the critical electronic systems we rely on.  Watson‐Marlow Fluid Technology Solutions is engineering vital fluid technology solutions that optimise the efficient use of resources and support advancements in global health, such as lifesaving vaccines and gene therapies. 

Spirax Group is headquartered in Cheltenham (UK). We have over 30 strategically located manufacturing plants around the world and are committed to creating a safe and inclusive working culture for our 10,000 colleagues, operating in nearly 70 countries and serving over 100,000 customers globally.   

The Company's shares have been listed on the London Stock Exchange since 1959 (symbol: SPX) and we are a constituent of the FTSE 100 and the FTSE4Good Indexes. 

 

* Eliminates scopes 1 and 2 greenhouse gas emissions when connected to a green electricity source. 

 

Further information can be found at spiraxgroup.com 

 

LEI 213800WFVZQMHOZP2W17 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100